TipRanks
Go Ultimate55% OFF

OWC Pharmaceutical Research (OWCP) Financial Statements

OWC Pharmaceutical Research Financial Overview

OWC Pharmaceutical Research's market cap is currently $497. The company's EPS TTM is $-0.00; its P/E ratio is 0.00; OWC Pharmaceutical Research is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 18Dec 17
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit――
Operating Income$ -4.30M$ -4.55M
EBITDA$ -3.56M$ -4.55M
Net Income$ -10.26M$ -4.56M
Balance Sheet
Cash & Short-Term Investments$ 3.46M$ 970.54K
Total Assets$ 3.55M$ 1.06M
Total Debt$ 0.00$ 0.00
Net Debt$ -3.46M$ -970.54K
Total Liabilities$ 12.99M$ 270.49K
Stockholders' Equity$ -9.44M$ 790.60K
Cash Flow
Free Cash Flow$ -2.53M$ -1.20M
Operating Cash Flow$ -2.50M$ -1.19M
Investing Cash Flow$ -28.00K$ -9.51K
Financing Cash Flow$ 5.02M$ 1.69M

Currency in USD

OWC Pharmaceutical Research Earnings and Revenue History

-12M-8M-4M00 %0.4 %0.8 %1.2 %EarningsProfit Margin20172018RevenueEarningsProfit Margin

OWC Pharmaceutical Research Debt to Assets

05M10M15M0 %150 %300 %450 %LiabilitiesDebt to Assets20172018AssetsLiabilitiesDebt to Assets

OWC Pharmaceutical Research Cash Flow

-4M-2M02M4M6M20172018OperatingInvestingFinancing

OWC Pharmaceutical Research Forecast EPS vs Actual EPS

0Q1 18EPS EstimateBeatMiss